Search research articles
Contact Us
Filters
Showing results (61-70 of 73) with videos related to
Page
of 8
Sort By:
British Journal of Cancer
|
October 1, 1987
Quantitation of MHC antigen expression on colorectal tumours and its association with tumour progression
L G Durrant, K C Ballantyne, N C Armitage, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)
|
September 1, 1993
Cell kinetics of the in vitro metaphase arrest technique and the clinical applications
P S Rooney, P A Clarke, K A Gifford, et al.
British Journal of Cancer
|
January 1, 1986
Antigenicity of newly established colorectal carcinoma cell lines
L G Durrant, R A Robins, M V Pimm, et al.
International Journal of Colorectal Disease
|
April 1, 1986
Symposium: Screening for colorectal cancer
F Macrae, G Ekelund, B P Robra, et al.
Cancer
|
July 1, 1986
Imaging of bone tumors using a monoclonal antibody raised against human osteosarcoma
N C Armitage, A C Perkins, M V Pimm, et al.
Gut
|
June 20, 2001
Risks, costs, and compliance limit colorectal adenoma surveillance: lessons from a randomised trial
J N Lund, J H Scholefield, M J Grainge, et al.
British Journal of Cancer
|
July 1, 1994
Congenital hypertrophy of the retinal pigment epithelium and mandibular osteomata as markers in familial colorectal cancer
L M Hunt, M H Robinson, C E Hugkulstone, et al.
British Journal of Cancer
|
December 1, 1987
Sensitivity of newly established colorectal cell lines to cytotoxic drugs and monoclonal antibody drug conjugates
L G Durrant, M C Garnett, J Gallego, et al.
Cancer Detection and Prevention. Supplement : Official Publication of the International Society for Preventive Oncology, Inc
|
January 1, 1987
Imaging of primary and metastatic colorectal carcinoma with monoclonal antibody 791T/36 and the therapeutic potential of antibody-drug conjugates
M V Pimm, N C Armitage, K Ballantyne, et al.
Gut
|
September 16, 1999
The risks of screening: data from the Nottingham randomised controlled trial of faecal occult blood screening for colorectal cancer
M H Robinson, J D Hardcastle, S M Moss, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 73) with videos related to
Sort By:
Page
of 8
British Journal of Cancer
|
October 1, 1987
Quantitation of MHC antigen expression on colorectal tumours and its association with tumour progression
L G Durrant, K C Ballantyne, N C Armitage, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)
|
September 1, 1993
Cell kinetics of the in vitro metaphase arrest technique and the clinical applications
P S Rooney, P A Clarke, K A Gifford, et al.
British Journal of Cancer
|
January 1, 1986
Antigenicity of newly established colorectal carcinoma cell lines
L G Durrant, R A Robins, M V Pimm, et al.
International Journal of Colorectal Disease
|
April 1, 1986
Symposium: Screening for colorectal cancer
F Macrae, G Ekelund, B P Robra, et al.
Cancer
|
July 1, 1986
Imaging of bone tumors using a monoclonal antibody raised against human osteosarcoma
N C Armitage, A C Perkins, M V Pimm, et al.
Gut
|
June 20, 2001
Risks, costs, and compliance limit colorectal adenoma surveillance: lessons from a randomised trial
J N Lund, J H Scholefield, M J Grainge, et al.
British Journal of Cancer
|
July 1, 1994
Congenital hypertrophy of the retinal pigment epithelium and mandibular osteomata as markers in familial colorectal cancer
L M Hunt, M H Robinson, C E Hugkulstone, et al.
British Journal of Cancer
|
December 1, 1987
Sensitivity of newly established colorectal cell lines to cytotoxic drugs and monoclonal antibody drug conjugates
L G Durrant, M C Garnett, J Gallego, et al.
Cancer Detection and Prevention. Supplement : Official Publication of the International Society for Preventive Oncology, Inc
|
January 1, 1987
Imaging of primary and metastatic colorectal carcinoma with monoclonal antibody 791T/36 and the therapeutic potential of antibody-drug conjugates
M V Pimm, N C Armitage, K Ballantyne, et al.
Gut
|
September 16, 1999
The risks of screening: data from the Nottingham randomised controlled trial of faecal occult blood screening for colorectal cancer
M H Robinson, J D Hardcastle, S M Moss, et al.
Page
of 8